Canadian Pharmacy Blog

On August 11, 2006, the FDA approved generic risedronate sodium tablets (Actonel, Procter & Gamble) 35 mg to increase bone mass in men with osteoporosis.
Actonel 5 mg was approved in 2000 for use in men and women to prevent and treat steroid-induced osteoporosis. Actonel 35 mg is also approved to prevent and treat osteoporosis in [...]

Reclast (zoledronic acid) injection (Novartis) has been approved as the first new treatment in nearly a decade for patients with Paget’s disease. It is given as a single 5-mg, 15-minute infusion; current oral therapies must be taken daily for up to six months.
Paget’s disease is a chronic, often painful bone disorder that causes abnormal bone [...]